About Gomel Regional Clinical Hospital
Clinical Trials at Gomel Regional Clinical Hospital
During the past decade, Gomel Regional Clinical Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gomel Regional Clinical Hospital" #1 sponsor was "Celgene" with 4 trials, followed by "Pfizer" with 3 trials
sponsored, "Abivax S.A." with 2 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Biocad"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gomel Regional Clinical Hospital"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Dr. Falk Pharma GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Gomel Regional Clinical Hospital
According to Clinical.Site data, the most researched conditions in "Gomel Regional Clinical Hospital" are
"Ulcerative Colitis" (10 trials), "Crohn's Disease" (2 trials), "Rheumatoid Arthritis" (2 trials), "Severe Hypertriglyceridemia" (2 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "Gomel Regional Clinical Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Gomel Regional Clinical Hospital
Most popular intervention types in "Gomel Regional Clinical Hospital" are "Drug" (24 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Etrasimod" (5 trials), "RPC1063" (3 trials), "Fenofibrate" (2 trials) and "K-877" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Gomel Regional Clinical Hospital
The vast majority of trials in "Gomel Regional Clinical Hospital" are
25 trials for "All" genders.
Clinical Trials Status at Gomel Regional Clinical Hospital
Currently, there are NaN active trials in "Gomel Regional Clinical Hospital".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Gomel Regional Clinical Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Gomel Regional Clinical Hospital, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".